Dermapharm Holding SE, DE000A2GS5D8

Dermapharm Holding SE, DE000A2GS5D8

07.09.2022 - 07:33:33

Dermapharm Holding SE publishes H1 2022 financial report, confirms outlook for 2022 overall

07.09.2022 CET/CEST Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.dgap.de

Language: English Company: Dermapharm Holding SE Lil-Dagover-Ring 7 82031 Gr?nwald

Germany Phone: +49 (0)89 64 86-0 E-mail: ir@dermapharm.com Internet: ir.dermapharm.de ISIN: DE000A2GS5D8 WKN: A2GS5D Indices: SDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange EQS News ID: 1436695 ? End of News DGAP News Service

1436695??07.09.2022?CET/CEST

@ dgap.de